Drawing for NANONAPROXIN

USPTO serial 75425506

NANONAPROXIN

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
OSBORNE, STANLEY
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NANONAPROXIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

STEPHEN A BENT

STEPHEN A BENT FOLEY & LARDNERP O BOX 25696WASHINGTON, DC 20007-8696UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely adjuvant preparations sold as a component of a full line of pharmaceuticals, and ingredients and components thereof, namely ultra-small particle formulationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 1, 1999ABN5ABANDONMENT - AFTER PUBLICATION—
Feb 1, 1999ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 29, 1998PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 27, 1998NPUBNOTICE OF PUBLICATION—
Sep 28, 1998CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 16, 1998DOCKASSIGNED TO EXAMINER—
Sep 14, 1998DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance